Cargando…
MicroRNA profiles involved in trifluridine resistance
Trifluridine (FTD) is a key component of the novel oral antitumor drug trifluridine/tipiracil, which is approved for the treatment of patients with metastatic colorectal cancer refractory to standard chemotherapies. A microRNA analysis of three colorectal cell lines was conducted to investigate caus...
Autores principales: | Tsunekuni, Kenta, Konno, Masamitsu, Asai, Ayumu, Koseki, Jun, Kobunai, Takashi, Takechi, Teiji, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581089/ https://www.ncbi.nlm.nih.gov/pubmed/28881790 http://dx.doi.org/10.18632/oncotarget.18078 |
Ejemplares similares
-
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Tsunekuni, Kenta, et al.
Publicado: (2019) -
Theoretical analyses and experimental validation of the effects caused by the fluorinated substituent modification of DNA
por: Koseki, Jun, et al.
Publicado: (2020) -
Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression
por: Matsuoka, Kazuaki, et al.
Publicado: (2018) -
Drug discovery of anticancer drugs targeting methylenetetrahydrofolate dehydrogenase 2
por: Asai, Ayumu, et al.
Publicado: (2018) -
Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer
por: Colvin, Hugh, et al.
Publicado: (2016)